The Chan Zuckerberg Initiative (CZI) and DAF, a Silicon Valley Community Foundation advised fund recently announced the awarding of a grant to ReadCoor, Inc. to spatially map cortical cells through Fluorescent in situ Sequencing (FISSEQ). ReadCoor already has a groundbreaking panomic spatial sequencing platform working to reinvent omics and pathology, and now joins the worldwide FISSEQ research project led by the Allen Institute.
Initially founded in December 2015 by Mark Zuckerberg and Priscilla Chan, the Chan Zuckerberg Initiative supports biomedical research and education through grant-making, advocacy work, and impact investing. The Initiative selects companies with innovative ideas regardless of their stage or structure, and supports them through a staff of engineers and experts combined with long-term investments.
ReadCoor has the first panomic spatial sequencing platform leveraging the new FISSEQ technology, and is delivering it to researchers, pharma, and diagnostics companies, with the end goal of benefitting patients. FISSEQ visualizes and reads the molecules of intact tissues through three-dimensional coordinates that can be applied to diagnostics and drug development.
“Our team is honored to be part of this consortium of world-leading academic scientists to contribute to the Human Cell Atlas,” said ReadCoor CEO Shawn Marcell. “We look forward to working with our fellow collaborators to deliver a robust map of cortical cells and transcend our foundational understanding of health and disease.”